[The effect of thymoptin in the specific immunotherapy of experimental microbial allergy].
Sukhodoeva
G S
GS
Shamsutdinova
G S
GS
Andreeva
N A
NA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D003131:Combined Modality Therapy; D003888:Desensitization, Immunologic / Q000379:methods*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology / Q000628:therapy*; D006969:Hypersensitivity, Immediate / Q000276:immunology / Q000628:therapy*; D007111:Immunity, Cellular / Q000187:drug effects; D007114:Immunization; D013203:Staphylococcal Infections / Q000276:immunology / Q000628:therapy*; D013947:Thymosin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D013949:Thymus Extracts; C065652:timoptin; D013947:Thymosin
Izuchenie vliianiia timoptina pri spetsificheskoĭ immunoterapii mikrobnoĭ allergii v éksperimente.